← Back to headlines
Eli Lilly's Next-Gen Obesity Drug Shows Superior Weight Loss in Trials
Eli Lilly's new obesity drug has demonstrated superior efficacy in trials, helping patients lose over 30% of their body weight and surpassing the performance of Ozempic and Mounjaro.
22 May, 05:17 — 22 May, 05:17
Sources
Showing 1 of 1 sources
